• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部区域治疗与免疫检查点抑制联合应用的现状。

Current State of Combination of Locoregional Therapies with Immune Checkpoint Inhibition.

机构信息

Department of Radiology, Medstar Georgetown University Hospital, 3800 Reservoir Rd NW, Washington, DC, 20007.

Department of Radiology, Medstar Georgetown University Hospital, 3800 Reservoir Rd NW, Washington, DC, 20007.

出版信息

J Vasc Interv Radiol. 2020 Nov;31(11):1740-1744.e9. doi: 10.1016/j.jvir.2020.07.011. Epub 2020 Oct 2.

DOI:10.1016/j.jvir.2020.07.011
PMID:33019993
Abstract

Advances in immunotherapy have changed the landscape of oncology over the past decade. Still, most patients with solid organ tumors do not derive a durable benefit from immunotherapies. How these tumors evade treatment has not been fully elucidated, but several studies are seeking ways to stimulate treatment response in these immunologically quiescent tumors. Of these, the combination of locoregional therapy with immune checkpoint inhibition is of interest to the interventional radiologist. This brief report provides an overview of current trials testing the effectiveness of locoregional therapy in combination with immune checkpoint inhibitors and identifies future research goals.

摘要

在过去的十年中,免疫疗法的进步改变了肿瘤学的格局。尽管如此,大多数实体器官肿瘤患者并未从免疫疗法中获得持久的益处。这些肿瘤如何逃避治疗尚未完全阐明,但有几项研究正在寻找刺激这些免疫静止肿瘤治疗反应的方法。在这些研究中,局部区域治疗与免疫检查点抑制联合应用引起了介入放射学家的兴趣。本简要报告概述了目前正在测试局部区域治疗联合免疫检查点抑制剂有效性的临床试验,并确定了未来的研究目标。

相似文献

1
Current State of Combination of Locoregional Therapies with Immune Checkpoint Inhibition.局部区域治疗与免疫检查点抑制联合应用的现状。
J Vasc Interv Radiol. 2020 Nov;31(11):1740-1744.e9. doi: 10.1016/j.jvir.2020.07.011. Epub 2020 Oct 2.
2
Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers.肿瘤基质重构与新型免疫疗法:基质衍生免疫生物标志物的前景。
J Immunother Cancer. 2018 Jul 3;6(1):65. doi: 10.1186/s40425-018-0376-0.
3
Immunomodulatory effects of current cancer treatment and the consequences for follow-up immunotherapeutics.当前癌症治疗的免疫调节作用及其对后续免疫治疗的影响。
Future Oncol. 2017 Aug;13(18):1649-1663. doi: 10.2217/fon-2017-0117. Epub 2017 Aug 4.
4
Interventional therapy combined with immune checkpoint inhibitors: Emerging opportunities for cancer treatment in the era of immunotherapy.介入治疗联合免疫检查点抑制剂:免疫治疗时代癌症治疗的新机遇。
Cancer Treat Rev. 2019 Mar;74:49-60. doi: 10.1016/j.ctrv.2018.08.006. Epub 2018 Aug 20.
5
Further Advances in Cancer Immunotherapy: Going Beyond Checkpoint Blockade.癌症免疫疗法的新进展:超越检查点阻断。
Front Immunol. 2018 Jun 1;9:1082. doi: 10.3389/fimmu.2018.01082. eCollection 2018.
6
Dendritic Cells and Their Role in Immunotherapy.树突状细胞及其在免疫疗法中的作用。
Front Immunol. 2020 May 21;11:924. doi: 10.3389/fimmu.2020.00924. eCollection 2020.
7
The importance for immunoregulation for long-term cancer control.免疫调节对于长期癌症控制的重要性。
Future Oncol. 2017 Aug;13(18):1619-1632. doi: 10.2217/fon-2017-0085. Epub 2017 Aug 4.
8
Immune checkpoint inhibitors: The linchpins of modern immunotherapy.免疫检查点抑制剂:现代免疫疗法的关键。
Immunol Rev. 2019 Jul;290(1):6-23. doi: 10.1111/imr.12766.
9
Emerging role of checkpoint inhibition in localized bladder cancer.检查点抑制在局限性膀胱癌中的新作用。
Urol Oncol. 2016 Dec;34(12):548-555. doi: 10.1016/j.urolonc.2016.09.004. Epub 2016 Oct 21.
10
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis.癌症免疫疗法的疗效与患者性别:系统评价和荟萃分析。
Lancet Oncol. 2018 Jun;19(6):737-746. doi: 10.1016/S1470-2045(18)30261-4. Epub 2018 May 16.

引用本文的文献

1
Combining energy-based focal ablation and immune checkpoint inhibitors: preclinical research and clinical trials.基于能量的聚焦消融与免疫检查点抑制剂联合应用:临床前研究与临床试验
Front Oncol. 2023 May 1;13:1153066. doi: 10.3389/fonc.2023.1153066. eCollection 2023.
2
Animal Models of Hepatocellular Carcinoma for Local-Regional Intraarterial Therapies.用于局部区域性肝动脉治疗的肝细胞癌动物模型。
Radiol Imaging Cancer. 2022 Jul;4(4):e210098. doi: 10.1148/rycan.210098.
3
Intratumoral Immunotherapy and Tumor Ablation: A Local Approach with Broad Potential.
瘤内免疫疗法与肿瘤消融:一种具有广泛潜力的局部治疗方法。
Cancers (Basel). 2022 Mar 30;14(7):1754. doi: 10.3390/cancers14071754.
4
New Developments in the Treatment of Hepatocellular Carcinoma: The Concept of Adjuvant and Neoadjuvant Chemotherapy.肝细胞癌治疗的新进展:辅助化疗和新辅助化疗的概念
J Clin Exp Hepatol. 2021 May-Jun;11(3):284-287. doi: 10.1016/j.jceh.2021.04.003. Epub 2021 Apr 27.